ProUroCare Medical Inc. (PUMD)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Mar 5, 2026
-50.00%
Market Cap 1.86K
Revenue (ttm) n/a
Net Income (ttm) -2.11M
Shares Out 18.60M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 6,137
Open 0.0001
Previous Close n/a
Day's Range 0.0001 - 0.0001
52-Week Range 0.0001 - 0.0002
Beta 18.50
RSI n/a
Earnings Date n/a

About ProUroCare Medical

ProUroCare Medical Inc. engages in developing products for the detection and characterization of male urological prostate disease. It offers the ProUroScan System, a prostate imaging system that aids the physician in documenting abnormalities in the prostate that have been previously detected by a digital rectal exam. The company has licensing, development, and commercialization agreements with Artann Laboratories Inc. for its ProUroScan System. ProUroCare Medical Inc. was founded in 1999 and is based in Eden Prairie, Minnesota. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1999
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol PUMD
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.